12:00 AM
 | 
Jun 10, 2013
 |  BC Week In Review  |  Company News  |  Deals

NovaBay, Virbac Group deal

NovaBay said animal health company Virbac exercised its option to acquire exclusive, worldwide rights to auriclosene ( NVC-422) for veterinary use under a March 2012 collaboration and license agreement. NovaBay will...

Read the full 136 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >